1. Adam M. Kaye, Pharm.D. , FASCP, FCPhA, Alan D. Kaye, MD, PhD, Elise C. Lofton, MD, Basic Concepts of Opioid Prescribing, Recent Reports of Unusual Opioid Mediated Toxicity, and Current Concepts of Opioid Medicated Effects in Driving. The Ochsner Journal.. The Ochsner Journal. Winter Edition, December 16, 2013
2. Jacqueline Volpi Abadie, Adam M. Kaye, Pharm.D., FASCP, FCPhA, Alan D. Kaye, MD, PhD. Serotonin Syndrome. The Ochsner Journal. . The Ochsner Journal. WINTER EDITION, December 16, 2013
3. Jacqueline Volpi Abadie, Adam M. Kaye, Pharm.D., FASCP, FCPhA, J. Michael Bensler, MD, FHRS, Alan D. Kaye, MD, PhD. QT Prolongation, Torsades de Pointes, and Drug-induced Long QT Interval. Journal of Anesthesia: Volume 27, Issue 4 (2013), Page 575-587
4. Charles E. Griffin III, MD Adam M. Kaye, Pharm.D., FASCP, FCPhA ,Franklin Rivera Bueno, MS3, Alan D. Kaye, MD, PhD. Benzodiazepine Pharmacology and Central Nervous System- Mediated Effects.. The Ochsner Journal. The Ochsner Journal: Summer 2013, Vol. 13, No. 2, pp. 214-223.
5. Adam M. Kaye, Pharm.D., FASCP, FCPhA Alvah T. Wickboldt, Alex F. Bowen, Aaron J. Kaye, Franklin Rivera Bueno, Alan D. Kaye, (2012) Sleep Physiology, Abnormal States, and Therapeutic Interventions. The Ochsner Journal: Summer 2012, Vol. 12, No. 2, pp. 122-134.
6. Adam M. Kaye, PharmD, FASCP, FCPhA, Andrew M. Abe, PharmD, Alan David Kaye, MD, PhD, Karina Gritsenko, MD, Perioperative Analgesia Considerations in Anesthesia Practice with Dietary Supplements. Journal: Best Practice & Research: Clinical Anaesthesiology.In press.
7. Patrick A. Torres, MD (anticipated, May, 2014), John A. Helmstetter, MD (anticipated, May, 2014), Adam M. Kaye, Pharm D, Alan David Kaye, MD PhD, Rhabdomyolysis, Pathogenesis, Diagnosis, and Treatment. The Ochsner Journal. In Press
8. Alan D Kaye MD, PhD, Adam M. Kaye,Pharm.D., Richard D. Urman MD.Editors. ESSENTIALS OF PHARMACOLOGY: Anesthesiology, Critical Care and Pain Medicine. In press.
9. Adam M. Kaye, PharmD, FASCP, FCPhA,What are the Normal Consequences of Aging? The Journal of Drug Intoxication & Detoxification: Novel Approaches 2012, 1:1 Volume 1, Issue 1.
10. Alan D. Kaye, MD, PhD, Amir Baluch, MD, Adam M. Kaye, PharmD, FASCP, FCPhA, Mineral, Vitamin, and Herbal Supplements. Anesthesia and Uncommon Diseases- Sixth Edition. Edited By Lee A. Fleisher. 2012, Chapter 16.
11. Alvah T. Wickboldt, Alex F. Bowen, Aaron J. Kaye, Adam M. Kaye, Pharm.D., FASCP, FCPhA, Franklin Rivera Bueno, Alan D. Kaye, MD, PhD. Sleep Physiology, Abnormal States, and Therapeutic Interventions. The Ochsner Journal, 2012 12:2, 122-134
12. Adam M. Kaye Pharm.D., FASCP, FCPhA & Jessica S. Kaye. Drugs that Cause Liver Toxicity. August 8, 2013. Featured Articles- RxEconsult, LLC.
13. Adam M. Kaye, Pharm.D., FASCP, FCPhA. Mirapex (pramipexole), Requip (ropinirole) and Impulse Control Disorders . June 18, 2012 . Featured Articles-RxEconsult, LLC.
14. Adam M. Kaye Pharm.D., FASCP, FCPhA & Jessica S. Kaye, Anticoagulants and Medications that Increase Risk of Bleeding. June 16, 2012. Featured Articles- RxEconsult, LLC.
15. Adam M. Kaye, Pharm.D., FASCP, FCPhA. Over-the-Counter (OTC) Antihistamines for Allergies. Featured Articles-RxEconsult, LLC. June 16, 2012.
16. Adam M. Kaye, Pharm.D., FASCP, FCPhA & Jessica S. KayeOver-the-Counter (OTC) Products for Insomnia. Featured Articles- RxEconsult, LLC. June 15, 2012.
17. Adam M. Kaye, Pharm.D., FASCP, FCPhA & Jessica S. Kaye, Opioid+NSAID Combinations and Stomach Bleeding. Featured Articles- RxEconsult, LLC. June 15, 2012.
18. Adam M. Kaye, Pharm.D., FASCP, FCPhA & Jessica S. Kaye, Should Statins be Used by Individuals with Low Risk for Heart Disease. Featured Articles- RxEconsult, LLC. June 15, 2012 .
19. Adam M. Kaye, Pharm.D., FASCP, FCPhA & Jessica S. Kaye, Prescription and Over-The-Counter (OTC) Acne Preparations. Featured Articles- RxEconsult, LLC. June 14, 2012.
20. Adam M. Kaye, Pharm.D. FASCP, FCPhA & Jessica S. Kaye,. Should Vicodin and other Hydrocodone Products be Switched to Schedule II. Featured Articles- June 2, 2012 RxEconsult, LLC.
21. Adam M. Kaye, Pharm.D. FASCP, FCPhA. How PBMs Affect the Future of Community Pharmacy. Featured Articles-RxEconsult, LLC. June 3, 2012
22. Adam M. Kaye, Pharm.D., FASCP, FCPhA, co-author. Ident-A-Drug Reference. Publisher: Pharmacists Letter 1999, 2000, 2001, 2002, 2003, 2004, 2005,2006, 2007, 2008,2009,2010,2011.
23. Adam M. Kaye, Pharm.D., FASCP, FCPhA, co-author. Opioid Guidelines 2012 American Society of Interventional Pain Physicians (ASIPP) Guidelines for Responsible Opioid Prescribing in Chronic Non-Cancer Pain: Part I – Evidence Assessment. Pain Physician 2012; 15:S1-S66 • ISSN 1533-3159. Approximately 55 co-authors from around the country are contributing to the creation of these important guidelines. Each considered an expert in the treatment of chronic pain.
24. Adam M. Kaye, Pharm.D., FASCP, FCPhA, co-author. Opioid Guidelines 2012 American Society of Interventional Pain Physicians (ASIPP) Guidelines for Responsible Opioid Prescribing in Chronic Non-Cancer Pain: Part 2 – Guidance. Pain Physician 2012; 15:S67-S116 • ISSN 1533-3159. Approximately 55 co-authors from around the country are contributing to the creation of these important guidelines. Each considered an expert in the treatment of chronic pain.